September 4, 2024 Sophia Vida
Breaking News

Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy

Company will use novel, patented Klotho Gene (s-KL) in studies New York, NY, September 4, 2024 – PRISM MediaWire – ANEW MEDICAL, INC. (NASDAQ: WENA), a U.S. biotechnology company, announced that it has two distinct goals for its pioneering cell and gene therapy development. One is to enhance the potential of people achieving a healthy … Continue reading “Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy”